The majority of first-line agents recommended for the treatment of adult hypertension (angiotensin converting enzyme inhibitors, angiotensin receptor blockers and diuretics) are not recommended in pregnancy due to potential teratogenicity and other fetal safety concerns [14–16]. This evidence concerns the gene ACE and hypertensive disorder.